Search results for: 'quantitative diseas analysi research'

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...

This analytics covers the EV mobility space and captures 300 EV-focused start-ups and their wide range of products and services catering to both the B2C and B2B markets. It also analyses all start-ups by segment: EV manufacturers, EV charging Infrastructure, EV battery technology, EV power electronics systems, and IT. EV battery technology and char...

This research service covers the leading ophthalmic diseases markets across the United States. The research service provides a detailed analysis of the revenue structure across this geographic segment. SWOT Analysis, strategic recommendations and market share analysis for the U.S. leading ophthalmic diseases markets have also been undertaken in t...

This research service evaluates the global autoimmune disease diagnostics markets from 2009 to 2018. The market includes two segments, which include analysis for the markets for localized autoimmune disease diagnostic tests and for the systemic autoimmune disease diagnostic tests. This research service offers a discussion of the key market drivers ...

The Frost & Sullivan Q1 2011 Vulnerability Tracker is compiled from various public sources to analyze the vulnerability landscape from 2000 to the present. Vulnerability data is collected, queried, and segmented, resulting in a wealth of information that is intended to provide qualitative commentary on the research industry and to recognize the mos...

The Frost & Sullivan Q2 2011 Vulnerability Tracker is compiled from various public sources to analyze the vulnerability landscape from 2000 to the present. Vulnerability data is collected, queried, and segmented, resulting in a wealth of information that is intended to provide qualitative commentary on the research industry and to recognize the mos...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

30 Mar 2016  |  Global  |  Market Research

Global Water Analysis Instrumentation Market, Forecast to 2022

Technological Innovations Effectively Address Need for Real-time Monitoring, Boosting Adoption by Industrial Sector

Infographics

×

This research service analyzes the global water analysis instrumentation market. The product segments covered include instruments such as Potential of Hydrogen/Oxidation Reduction Potential (pH/ORP), dissolved oxygen, total organic carbon, conductivity, turbidity, and chlorine. Revenue forecasts have been provided for instruments based on form fact...

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...